Methaemoglobinaemia Pathology
On this page
Direct answer
Haemoglobin carries oxygen only while its iron stays ferrous (Fe2+); oxidation to the ferric (Fe3+) state creates methaemoglobin, which cannot bind oxygen and left-shifts the oxygen-dissociation curve of the remaining normal haem groups — tissues are starved twice over. Normal blood holds methaemoglobin below 1 per cent, kept there by NADH-dependent cytochrome-b5 reductase; disease therefore appears when the enzyme is inherited deficient (autosomal recessive; type I confined to erythrocytes, type II with severe neurological features) or when an oxidant overwhelms the system — dapsone, nitrates in contaminated well water, prilocaine and benzocaine, aniline dyes. Chocolate-brown blood, cyanosis unresponsive to oxygen with a normal arterial PaO2, and a pulse oximeter reading improbably stuck near 85 per cent form the diagnostic signature; co-oximetry confirms the level.
What you must remember
- Thresholds to quote: normal methaemoglobin under 1 per cent; chocolate-brown cyanosis evident from about 10-15 per cent; headache, fatigue and dyspnoea above 20-30 per cent; confusion and acidosis in the 30-50 per cent band; levels beyond about 60-70 per cent are usually lethal.
- Enzymology in one line: the NADH–cytochrome-b5 reductase pathway handles over 95 per cent of daily reduction, with a minor NADPH-dependent pathway — which matters because methylene blue works through NADPH, and G6PD deficiency cripples it.
- Drug and chemical causes with anchors: dapsone (the leprosy workhorse under India's National Leprosy Eradication Programme, and its hydroxylamine metabolite), nitrate-contaminated well water (infantile methaemoglobinaemia in rural agricultural belts — the classical Indian public-health case), benzocaine and prilocaine topical anaesthesia, aniline dyes, and chloroquine or primaquine.
- Hereditary forms: cytochrome-b5 reductase deficiency (type I — chronic cyanosis only, well tolerated; type II — severe mental retardation and microcephaly, because the enzyme is ubiquitous) and haemoglobin M disease — a dominant globin-chain mutation (histidine to tyrosine) that stabilises iron in the ferric state and resists both enzyme and dye therapy.
- Investigation logic: arterial blood that is chocolate-brown and remains brown on filter paper, unlike normal blood which dries red; pulse oximeter reads saturation around 85 per cent regardless of the true level, creating a saturation gap; co-oximetry measures methaemoglobin directly.
- Treatment ladder: withdraw the agent; methylene blue 1-2 mg/kg intravenously (which itself is reduced to leucomethylene blue via NADPH to reduce ferric iron); ascorbic acid as an adjunct; exchange transfusion or hyperbaric oxygen for extreme or refractory cases.
- Contraindication to memorise: methylene blue in G6PD deficiency — it fails (no NADPH) and adds oxidative haemolysis; ascorbate and transfusion carry the case instead.
Blue lips on dapsone: a worked case
A 24-year-old on dapsone for borderline lepromatous leprosy returns with bluish lips and fingernails, vague headache, and no dyspnoea at rest. Pulse oximetry reads 86 per cent on room air, yet supplemental oxygen changes nothing — the first alarm. Arterial blood gas shows a normal PaO2 (the oxygen that is dissolved and unbound measures normally) with the blood itself an unmistakable chocolate brown that does not revert on shaking in air. Co-oximetry returns methaemoglobin at 28 per cent. Management unfolds in order: stop the dapsone, check the G6PD assay before reaching for the antidote, and if G6PD is normal give methylene blue 1-2 mg/kg intravenously, watching the lips pink up within an hour. If the patient were G6PD-deficient — not rare in the very populations treated for leprosy — the dye would be withheld for ascorbate and, if severe, exchange transfusion. The final exam-worthy sentence: dapsone-related methaemoglobinaemia is dose- and metabolite-mediated, so it can appear months into a standard regimen, not only in overdose.
How the exam frames it
Three questions recur. First, the saturation gap — oximeter around 85 per cent with a normal PaO2 — is virtually pathognomonic when oxygen does not help. Second, why methylene blue fails in G6PD deficiency: its recycling requires the NADPH generated by the pentose phosphate pathway. Third, haemoglobin M disease: a dominant condition, cyanosis from birth, methylene blue useless because the ferric state is stabilised within the globin chain itself. Add the infant fed on nitrate-rich well-water formula — methaemoglobinaemia's public-health face in rural India — and the topic is fully covered.
Frequently asked questions
Why does methaemoglobin cause cyanosis at low levels?
Ferric haemoglobin appears dark, and even one oxidised haem group left-shifts the oxygen-dissociation curve of the remaining haem groups, impairing unloading.
What is the saturation gap?
A pulse oximeter improbably fixed near 85 per cent while the PaO2 is normal — the bedside signature of methaemoglobinaemia.
Why is methylene blue contraindicated in G6PD deficiency?
The dye is reduced to leucomethylene blue through the NADPH of the pentose phosphate pathway, which G6PD deficiency disables — so it is both ineffective and haemolytic.
Which Indian clinical setting classically produces methaemoglobinaemia?
Dapsone therapy in leprosy, and infantile methaemoglobinaemia from nitrate-contaminated well water in agricultural regions.
What is haemoglobin M disease?
A dominant globin mutation stabilising iron in the ferric form, causing lifelong cyanosis resistant to methylene blue treatment.